INMB INMUNE BIO INC Other Situations 8-K Filing 2024 - Other Events INmune Bio announced the completion of the first cohort and initiation of the second cohort of a study for INKmune Natural Killer cell therapy in patients with prostate cancer, as well as an update on two patients receiving XPro for Alzheimer's treatment.Get access to all SEC 8-K filings of the INMUNE BIO INC